NEW YORK, May 29, 2025 /PRNewswire/ — AiCure, a leading AI and advanced data analytics company focused on transforming clinical trials and patient engagement, today announced the appointment of Sabina Chadha as its new Chief Executive Officer. Current CEO Ed Ikeguchi, M.D., will transition to the role of Chief Medical Officer, where he will continue to drive the company’s clinical vision and innovation. Additionally, AiCure has promoted Josh Wilson to Chief Operating Officer and President, reflecting his significant contributions to operational excellence, product strategy, and company growth.
Sabina Chadha brings a wealth of experience in strategic planning, execution, and management to AiCure. Known for her organizational acumen and detail-oriented approach, Chadha has consistently demonstrated the ability to align teams around a shared vision and deliver measurable business growth. Sabina brings over two decades of experience scaling high-growth technology companies, particularly in the healthcare sector. Prior to joining AiCure, she held executive roles at Skedulo, InVita Healthcare Technologies, SmartLinx Solutions, and Management Health Solutions, where she drove significant revenue growth, led successful mergers and acquisitions, and developed strategic partnerships with industry leaders such as Oracle, Cerner, and SAP.
Chadha’s leadership philosophy centers on people and culture, recognizing that empowered teams are essential for innovation and scaling success. She is adept at fostering cross-functional collaboration, developing robust partner networks, revitalizing product innovation, implementing best practices in operational excellence and financial analysis—skills that will be instrumental as AiCure expands its AI-powered clinical trial solutions.
Dr. Ed Ikeguchi, who has led AiCure as CEO since 2020, will now focus on advancing clinical strategy and technology as Chief Medical Officer. Under his leadership, AiCure has pioneered AI-powered solutions that improve patient adherence and trial outcomes, including the launch of the H.Code platform, which blends computer vision, app-based communication, and predictive analytics to enhance participant engagement and data quality.
Josh Wilson, previously Senior Vice President of Operations, has been promoted to Chief Operating Officer and President. In his expanded role, Wilson will oversee all product strategy and operational aspects of the company, steering strategic initiatives to further AiCure’s mission of improving clinical trials and the patient experience through innovative AI-powered solutions. Wilson joined AiCure in 2022 and has been instrumental in advancing AiCure’s operational capabilities and enhancing the delivery of its platform and site services. Wilson brings over two decades of experience in clinical research operations and digital health technologies, with a proven track record at leading organizations such as Syneos Health and INC Research.
“Sabina’s leadership and operational expertise are exactly what AiCure needs as we enter our next phase of growth,” said Dr. Ed Ikeguchi. “Her vision aligns perfectly with our commitment to transforming clinical trials and patient engagement. I am excited to focus on our clinical innovation as Chief Medical Officer, and I am confident that Josh’s operational leadership will further strengthen our ability to deliver impactful solutions to our clients and partners.”
These leadership transitions underscore AiCure’s commitment to advancing the clinical trial experience for participants, sites, and sponsors through cutting-edge AI technology and operational excellence.
About AiCure
AiCure is a leading AI and advanced data analytics company deploying H.Code, a patient engagement platform that reinvents the clinical trial experience using AI-assisted dosing and compliance tools, seamless app-based communication, and comprehensive site services. AiCure makes clinical trials more accessible and rewarding for participants and more efficient and effective for sponsors and study teams.
For more information, visit aicure.com.
Media Contact:
John Stanton
Marketing Director
john.stanton@aicure.com
SOURCE AiCure
An In-Depth Analysis of Digital Sound Frequency Programs, Binaural Beats Research, and Key Considerations for…
Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research…
The Best SARMS for Strength, Cutting, Muscle Growth, Body Building & Recovery - A Guide…
Ozempic for Weight Loss: Does It Work and Is It Safe? Read PhenQ Details –…
Prescription NAD+ Injection Access, At-Home Administration Models, Compounding Standards, and What Consumers Should Know Before…
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…